$LXEO 4 SEC Filings

Filed On	Filing
28 Sep 2026	Form 4: Bhalla Narinder Pal, Chief Medical Officer Received 2,714 shares as a grant or award ($9.71K) · Granted 54,750 Stock Option (right to buy)
28 Sep 2026	Form 4: Tamayo Louis Edward, Chief Financial Officer Granted 54,750 Stock Option (right to buy)
28 Sep 2026	Form 4: Otero Jose Manuel, Chief Operating Officer Received 2,110 shares as a grant or award ($5.58K) · Granted 54,750 Stock Option (right to buy)
28 Sep 2026	Form 4: Townsend Richard Nolan, Director Received 2,306 shares as a grant or award ($6.1K) · Granted 145,500 Stock Option (right to buy)
19 Aug 2026	Form 4: Tamayo Louis Edward, Chief Financial Officer Sold 4,117 shares ($20.2K)
19 Aug 2026	Form 4: Townsend Richard Nolan, Director Sold 3,345 shares ($16.6K)
19 Aug 2026	Form 4: Otero Jose Manuel, Chief Operating Officer Sold 1,304 shares ($6.46K)
01 Jul 2026	Form 4: Tamayo Louis Edward, Chief Financial Officer Received 12,000 shares as a grant or award · Sold 4,641 shares ($20.8K)
01 Jul 2026	Form 4: Otero Jose Manuel, Chief Operating Officer Received 12,060 shares as a grant or award · Sold 4,666 shares ($20.9K)
01 Jul 2026	Form 4: Bhalla Narinder Pal, Chief Medical Officer Received 55,000 shares as a grant or award · Sold 22,306 shares ($98.6K)
01 Jul 2026	Form 4: Townsend Richard Nolan, Director Received 67,000 shares as a grant or award · Sold 25,947 shares ($116K)
29 Jun 2026	Form 4: Altschuler Steven, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Agger Mette Kirstine, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Cooperstone Brenda, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Diaz Reinaldo M, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Tanguler Tolga, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Van Hauwermeiren Timothy, Director Granted 35,000 Stock Option (right to buy)
29 Jun 2026	Form 4: Cholmondeley Paula H, Director Granted 35,000 Stock Option (right to buy)
20 May 2026	Form 4: Otero Jose Manuel, Chief Operating Officer Sold 1,302 shares ($6.61K)
20 May 2026	Form 4: Townsend Richard Nolan, Director Sold 3,342 shares ($16.9K)

Comments